Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical Cancer Research

• Publication date

  2003-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14581379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclooxygenase 2: a molecular target for cancer prevention and treatment.

  2003cited by this paper
• The clinical development of the bryostatins

  2002cited by this paper
• Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.

  2002cited by this paper
• CHAPTER 12 – BIOSYNTHETIC PRODUCTS FOR ANTICANCER DRUG DESIGN AND TREATMENT: THE BRYOSTATINS

  2002cited by this paper
• Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms.

  2002cited by this paper
• Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.

  2002cited by this paper
• Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer.

  2001cited by this paper
• Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells*

  2001cited by this paper
• Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44*

  2001cited by this paper
• Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice*

  2001cited by this paper
• Thalidomide and its analogues inhibit lipopolysaccharide-mediated Iinduction of cyclooxygenase-2.

  2001cited by this paper
• Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity

  2001cited by this paper
• Cyclooxygenase-2 is overexpressed in human cervical cancer.

  2001cited by this paper
• The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.

  2000cited by this paper
• Microtubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2

  2000cited by this paper
• Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.

  2000cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.

  1999cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet light–induced skin carcinogenesis

  1999cited by this paper
• Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.

  1999cited by this paper
• Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion.

  1999cited by this paper
• AP-1 Factors Play an Important Role in Transformation Induced by the v-rel Oncogene

  1998cited by this paper
• Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.

  1998cited by this paper
• Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice.

  1998cited by this paper
• Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.

  1998cited by this paper
• Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2*

  1998cited by this paper
• Ceramide Regulates the Transcription of Cyclooxygenase-2

  1998cited by this paper
• Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

  1998cited by this paper
• Cyclooxygenase-2 gene expression in human breast cancer.

  1997cited by this paper
• Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2.

  1997cited by this paper
• Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

  1997cited by this paper
• Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

  1997cited by this paper
• Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells.

  1997cited by this paper
• Expression of cyclooxygenase-2 in human gastric carcinoma.

  1997cited by this paper
• Outcome of specific COX-2 inhibition in rheumatoid arthritis.

  1997cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.

  1996cited by this paper
• Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

  1996cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Transcriptional Regulation of Human Prostaglandin-endoperoxide Synthase-2 Gene by Lipopolysaccharide and Phorbol Ester in Vascular Endothelial Cells

  1995cited by this paper
• Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis

  1995cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.

  1994cited by this paper
• Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents.

  1994cited by this paper
• Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

  1994cited by this paper
• A phase I study of intravenous bryostatin 1 in patients with advanced cancer.

  1993cited by this paper
• Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

  1993cited by this paper
• Characterization of 21 newly established esophageal cancer cell lines

  1992cited by this paper
• Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.

  1992cited by this paper
• TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

  1991cited by this paper
• Successful treatment of murine melanoma with bryostatin 1.

  1991cited by this paper
• Identification of a phorbol ester-repressible v-src-inducible gene.

  1989cited by this paper
• Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck.

  1988cited by this paper
• Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells.

  1986influential reference
• Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

  1986cited by this paper
• Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.

  1986influential reference
• ALTERATIONS IN THE

  1985cited by this paper
• Isolation and structure of bryostatin 1

  1982cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Marine derived macrolide bryostatin 4 inhibits the TGF-β signaling pathway against acute erythroleukemia

  2024cites this paper
• Regulation of inflammation and COX-2 gene expression in benzo (a) pyrene induced lung carcinogenesis in mice by all trans retinoic acid (ATRA).

  2021cites this paper
• The Phylum Bryozoa: From Biology to Biomedical Potential

  2020cites this paper
• Marine Niche: Applications in Pharmaceutical Sciences: Translational Research

  2020cites this paper
• Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus

  2019cites this paper
• Bioactive Compounds from Marine Sources for Gastrointestinal Cancer Treatment

  2012cites this paper
• The development of immune-modulating compounds to disrupt HIV latency.

  2012cites this paper
• Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

  2011cites this paper
• Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.

  2008cites this paper
• Effects of Iejimalide B, a marine macrolide, on growth and apoptosis in prostate cancer cell lines

  2008cites this paper
• Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells.

  2008cites this paper
• Novel marine-derived anti-cancer agents.

  2007cites this paper
• Antitumor and anti-invasive effects of diverse new macrocyclic lactones, alkylolides and alkenylolides, and their enhancement by hyperthermia.

  2007cites this paper
• Marine pharmacology in 2003-2004: anti-tumour and cytotoxic compounds.

  2006cites this paper
• Green tea polyphenol (−)‐epigallocatechin‐3‐gallate inhibits cyclooxygenase‐2 expression in colon carcinogenesis

  2006cites this paper
• Methode de traitement de la maladie d'alzheimer et d'amelioration cognitive

  2005cites this paper
• The action of the mast cell product tryptase on cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation involves activation of the extracellular signal-regulated kinase isoforms 1 and 2 (erk1/2).

  2005cites this paper
• Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer.

  2005cites this paper